propylhexedrine
(JCRIVQIOJSSCQD-UHFFFAOYSA-N)
Structure
- SMILES
- CNC(CC1CCCCC1)C
- Type(s)
- Approved
- Molecular Formula:
- C10H21N
- Molecular Weight:
- 155.280
- Log P:
- 2.9556
- Hydrogen Bond Acceptor:
- 1
- Hydrogen Bond Donor:
- 1
- TPSA:
- 12.03
- CAS Number(s):
- 101-40-6; 6192-98-9
Synonym(s)
1.
propylhexedrine
2.
Benzedrex
3.
propylhexadrine
4.
propylhexedrine hydrochloride
5.
propylhexedrine hydrochloride, (S)-isomer
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Epistaxis | FAERS: 4 | US FAERS | |
| 2 | Sinusitis | FAERS: 4 | US FAERS | |
| 3 | Drug Dependence | FAERS: 2 | US FAERS | |
| 4 | Drug abuse | FAERS: 2 | US FAERS | |
| 5 | Euphoric mood | FAERS: 2 | US FAERS | |
| 6 | Fatigue | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Feeling abnormal | FAERS: 2 | US FAERS | |
| 8 | Incorrect dose administered | FAERS: 2 | US FAERS | |
| 9 | Agitation | FAERS: 1 | US FAERS | |
| 10 | Crying | FAERS: 1 | US FAERS | |
| 11 | Dissociation | FAERS: 1 | US FAERS | |
| 12 | Dizziness | FAERS: 1 | US FAERS | |
| 13 | Drug ineffective | FAERS: 1 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 14 | Headache | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 16 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 17 | Lethargy | FAERS: 1 | US FAERS | |
| 18 | Limb discomfort | FAERS: 1 | US FAERS | |
| 19 | Nasal discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Nervousness | FAERS: 1 | US FAERS | |
| 21 | Pain | FAERS: 1 | US FAERS | |
| 22 | Restlessness | FAERS: 1 | US FAERS | |
| 23 | Sneezing | FAERS: 1 | US FAERS | |
| 24 | Unevaluable event | FAERS: 1 | US FAERS | |
| 25 | Abdominal Pain | Canada Vigilance: 4 | Canada Vigilance | |
| 26 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Conjunctivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Duodenal Ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Dysgeusia | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Pharyngeal swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Poor quality product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Product container issue | Canada Vigilance: 1 | Canada Vigilance | |
| 35 | Product quality issue | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Product storage error | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Product substitution issue | Canada Vigilance: 1 | Canada Vigilance | |
| 38 | Rhinitis | Canada Vigilance: 2 | Canada Vigilance | |
| 39 | Scab | Canada Vigilance: 1 | Canada Vigilance | |
| 40 | Somnolence | Canada Vigilance: 2 | Canada Vigilance | |
| 41 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 42 | Therapeutic product effect incomplete | Canada Vigilance: 3 | Canada Vigilance | |
| 43 | Urticaria | Canada Vigilance: 1 | Canada Vigilance | |
| 44 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.